Keyphrases
Indonesia
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
64%
Recombinant
37%
Jakarta
35%
HIV Patients
34%
AIDS/HIV
29%
Enhanced Green Fluorescent Protein (eGFP)
29%
Escherichia Coli
27%
Annona muricata
26%
Cell-penetrating Peptide
26%
COVID-19
26%
Plasma Samples
26%
People Living with HIV (PLHIV)
24%
Quantitative PCR
21%
Colorectal Cancer Cells
20%
Leaf Extract
20%
Expression in Escherichia Coli
20%
HIV RNA
20%
Escherichia Coli BL21
19%
Plasmid
17%
RT-PCR Assay
17%
Severe Acute Respiratory Syndrome-associated Coronavirus
17%
Genotyping Assay
17%
Cytomegalovirus
17%
Human Detection
17%
National Hospital
17%
Primer Pairs
17%
CRF01_AE
17%
Cancer Cells
17%
Biofilm
17%
Serological Test
16%
Colorectal Cancer
15%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
15%
Antiretroviral Therapy
14%
N Protein
14%
SARS-CoV-2 Vaccine
13%
E. Coli BL21
12%
DLD-1
12%
Drug Resistance
12%
Placebo
12%
Antiproliferative Activity
11%
Cytotoxic Activity
11%
Gp41
11%
Indonesian
11%
Conjunctival Swab
11%
Immune Response
11%
Immunodiagnostics
11%
PCR Method
11%
HIV Drug Resistance
11%
Virological Failure
11%
Immunology and Microbiology
Human Immunodeficiency Virus
98%
Human Immunodeficiency Virus 1
72%
Escherichia coli
33%
Blood Plasma
25%
Reverse Transcription Polymerase Chain Reaction
22%
Drug Resistance
21%
Plasmid
19%
Peptides
18%
Cell Population
17%
T Cell
17%
Coronavirinae
17%
Severe Acute Respiratory Syndrome
17%
Cytomegalovirus
17%
Virus Nucleocapsid
17%
Western Blot
14%
Serology
14%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Immunodiagnostics
11%
Gp41
10%
Immune Response
10%
Inflammation Response
10%
ELISA
10%
Amino Acid
10%
Hemagglutinin
9%
Cross-Reactivity
9%
Influenza
9%
CD44
8%
Lactobacillus plantarum
8%
Colon
8%
Tocilizumab
8%
Receptor Binding
8%
Dengue Fever
8%
Scale up
8%
Genotyping Technique
8%
Antigen Expression
8%
Methylotrophic Yeast
8%
Ogataea angusta
8%
L1 (Protein)
8%
Long Terminal Repeat
8%
Internal Ribosome Entry Site
8%
Murine Leukemia Virus
8%
Biofilm
8%
COVID-19
8%
Amylase
8%
Cervarix
8%
Mycobacterium leprae
8%
Hemolysin
8%
Human Papillomavirus Type 52
8%
Cytokine
8%
Integrase
8%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
78%
SARS Coronavirus
36%
Coronavirinae
35%
Escherichia coli
34%
Colorectal Carcinoma
28%
Severe Acute Respiratory Syndrome
28%
Annona muricata
26%
Cytotoxicity
20%
COVID-19 Vaccine
19%
Cell Penetrating Peptide
17%
Placebo
16%
Malignant Neoplasm
16%
Diseases
15%
Guanine Nucleotide Binding Protein
14%
Pseudomonas aeruginosa
13%
HIV Drug Resistance
10%
Binding Site
10%
Enzyme-Linked Immunosorbent Assay
10%
RNA Directed DNA Polymerase
9%
Nonnucleoside Reverse Transcriptase Inhibitor
9%
Human Immunodeficiency Virus 1
8%
DNA Immunization
8%
Flavonoid
8%
Lactobacillus plantarum
8%
Dry Eye
8%
Epitope
8%
Proteinase K
8%
Legionella
8%
Chimeric Protein
8%
Colon Carcinoma
8%
Nucleocapsid Protein
8%
Methylotrophic Yeast
8%
Ogataea angusta
8%
Messenger RNA
8%
Caspase
8%
Antiproliferative Activity
8%
Neuropathy
8%
Wart Virus Vaccine
8%
Cytokine
8%
Phytochemical
8%
Hemolysin
8%
Receptor
8%
Bagg Albino Mouse
8%
Transcription Factors
8%
Amikacin
8%
Immunoglobulin G
8%
Interleukin 2
8%
Human Papillomavirus Type 52
8%
Carbapenem
8%
Subunit Vaccine
8%
